Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non‐alcoholic fatty liver disease
Weijun Wang, Jinfang Zhao, Wenfang Gui, et al.
British Journal of Pharmacology (2017) Vol. 175, Iss. 3, pp. 469-484
Open Access | Times Cited: 154

Showing 1-25 of 154 citing articles:

Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis
Yong Rao, Zhiqi Kuang, Chan Li, et al.
Gut Microbes (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 213
Endoplasmic reticulum stress in liver diseases
Amir Ajoolabady, Neil Kaplowitz, Cynthia Lebeaupin, et al.
Hepatology (2022) Vol. 77, Iss. 2, pp. 619-639
Open Access | Times Cited: 188
Tauroursodeoxycholate—Bile Acid with Chaperoning Activity: Molecular and Cellular Effects and Therapeutic Perspectives
Magdalena Kusaczuk
Cells (2019) Vol. 8, Iss. 12, pp. 1471-1471
Open Access | Times Cited: 169
Gut microbiota modulation in patients with non-alcoholic fatty liver disease: Effects of current treatments and future strategies
Marta Maestri, Francesco Santopaolo, Maurizio Pompili, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 46
Bile Acids, Intestinal Barrier Dysfunction, and Related Diseases
Linsen Shi, Lihua Jin, Wendong Huang
Cells (2023) Vol. 12, Iss. 14, pp. 1888-1888
Open Access | Times Cited: 43
Tea Polyphenol Epigallocatechin Gallate Protects Against Nonalcoholic Fatty Liver Disease and Associated Endotoxemia in Rats via Modulating Gut Microbiota Dysbiosis and Alleviating Intestinal Barrier Dysfunction and Related Inflammation
Gaolong Zuo, Meiyan Chen, Yingpeng Zuo, et al.
Journal of Agricultural and Food Chemistry (2024)
Closed Access | Times Cited: 18
Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome
Maja Đanić, Bojan Stanimirov, Nebojša Pavlović, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 108
Interactions between gut microbiota and non-alcoholic liver disease: The role of microbiota-derived metabolites
Yufang Ding, Karin Yanagi, Clint Cheng, et al.
Pharmacological Research (2019) Vol. 141, pp. 521-529
Open Access | Times Cited: 100
The Food Additive Maltodextrin Promotes Endoplasmic Reticulum Stress–Driven Mucus Depletion and Exacerbates Intestinal Inflammation
Federica Laudisi, Davide Di Fusco, Vincenzo Dinallo, et al.
Cellular and Molecular Gastroenterology and Hepatology (2018) Vol. 7, Iss. 2, pp. 457-473
Open Access | Times Cited: 98
Bile Acids and Microbiota: Multifaceted and Versatile Regulators of the Liver–Gut Axis
Niklas Grüner, Jochen Mattner
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1397-1397
Open Access | Times Cited: 95
Effect of different bile acids on the intestine through enterohepatic circulation based on FXR
Junwei Xiang, Zhengyan Zhang, Hong-Yi Xie, et al.
Gut Microbes (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 80
The Role of the Gut-Liver Axis in Metabolic Dysfunction-Associated Fatty Liver Disease
Rosa Martín‐Mateos, Agustı́n Albillos
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 78
Sodium Alginate Modulates Immunity, Intestinal Mucosal Barrier Function, and Gut Microbiota in Cyclophosphamide-Induced Immunosuppressed BALB/c Mice
Juan Huang, Jinli Huang, Yao Li, et al.
Journal of Agricultural and Food Chemistry (2021) Vol. 69, Iss. 25, pp. 7064-7073
Closed Access | Times Cited: 78
Traumatic Brain Injury Induces Gastrointestinal Dysfunction and Dysbiosis of Gut Microbiota Accompanied by Alterations of Bile Acid Profile
Wendong You, Yuanrun Zhu, Anqi Wei, et al.
Journal of Neurotrauma (2021) Vol. 39, Iss. 1-2, pp. 227-237
Closed Access | Times Cited: 58
Bile acids and their receptors in regulation of gut health and diseases
Sen Lin, Sutian Wang, Peng Wang, et al.
Progress in Lipid Research (2022) Vol. 89, pp. 101210-101210
Open Access | Times Cited: 50
Versatile Triad Alliance: Bile Acid, Taurine and Microbiota
Kalina Duszka
Cells (2022) Vol. 11, Iss. 15, pp. 2337-2337
Open Access | Times Cited: 41
Coprophagy Prevention Affects the Reproductive Performance in New Zealand White Rabbits Is Mediated through Nox4-ROS-NFκB Pathway
Zhichao Li, Ruiting Li, Jing Li, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 39
Enhancing intestinal barrier efficiency: A novel metabolic diseases therapy
Yaoyuan Zhang, Zhu Xiao, Xinyuan Yu, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 38
Dietary Fiber and Its Potential Role in Obesity: A Focus on Modulating the Gut Microbiota
Shuhua Tian, Qiang Chu, Shaotong Ma, et al.
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 41, pp. 14853-14869
Closed Access | Times Cited: 26
A Current Understanding of FXR in NAFLD: The multifaceted regulatory role of FXR and novel lead discovery for drug development
Tang Yu-hong, Yujuan Fan, Yiming Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116658-116658
Open Access | Times Cited: 11
Dysregulated bile acid homeostasis: unveiling its role in metabolic diseases
Yanyan Wang, Huangru Xu, Xiqiao Zhou, et al.
Medical Review (2024) Vol. 4, Iss. 4, pp. 262-283
Open Access | Times Cited: 8
Tauroursodeoxycholic Acid Improves Nonalcoholic Fatty Liver Disease by Regulating Gut Microbiota and Bile Acid Metabolism
Huan Wang, Yi Guo, Weiting Han, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 36, pp. 20194-20210
Closed Access | Times Cited: 8
Neohesperidin attenuates obesity by altering the composition of the gut microbiota in high‐fat diet‐fed mice
Jun Lu, Mengqing Zhu, Heng Zhang, et al.
The FASEB Journal (2020) Vol. 34, Iss. 9, pp. 12053-12071
Closed Access | Times Cited: 59
Role of FXR in Bile Acid and Metabolic Homeostasis in NASH: Pathogenetic Concepts and Therapeutic Opportunities
Richard Radun, Michael Trauner
Seminars in Liver Disease (2021) Vol. 41, Iss. 04, pp. 461-475
Open Access | Times Cited: 51
Hepatocyte TGF‐β Signaling Inhibiting WAT Browning to Promote NAFLD and Obesity Is Associated With Let‐7b‐5p
Jinfang Zhao, Lilin Hu, Wenfang Gui, et al.
Hepatology Communications (2022) Vol. 6, Iss. 6, pp. 1301-1321
Open Access | Times Cited: 31
Page 1 - Next Page

Scroll to top